Recurrence Reduction

Recurrence Reduction is a clinical outcome metric in oncology that quantifies the extent to which adjuvant chemotherapy decreases the incidence of cancer relapse following primary treatment.

231

Publications

19.4K

Citations

2.2K

Authors

709

Institutions

Publications per year

2017–2026

64

Authors

2.2K

  1. BG
    Bengt Glimelius

    Uppsala University, Sweden

    6 publications · 1.1K citations

    6

    h-index

  2. CJ
    Cornelis J.�H. van de Velde

    Leiden University Medical Center, Netherlands

    5 publications · 1.3K citations

    5

    h-index

  3. EM
    Elma Meershoek‐Klein Kranenbarg

    Leiden University Medical Center, Netherlands

    4 publications · 1.2K citations

    4

    h-index

  4. KM
    Kjell M. Tveit

    Norwegian Cancer Society, Norway

    4 publications · 445 citations

    4

    h-index

  5. DS
    David Sebag‐Montefiore

    University of Leeds, United Kingdom

    4 publications · 210 citations

    4

    h-index

1–5 of 2.2K

Venues

  1. Journal of Clinical Oncology

    19 publications · 3K citations

    16

    h-index

  2. PubMed

    Repository · 17 publications · 564 citations

    13

    h-index

  3. Annals of Surgical Oncology

    9 publications · 478 citations

    9

    h-index

  4. Cancer

    9 publications · 938 citations

    9

    h-index

  5. British journal of surgery

    BJS · 6 publications · 396 citations

    6

    h-index

1–5